Somatic mosaicism and interneuron involvement in mTORopathies

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Somatic mutations in mechanistic target of rapamycin (mTOR) pathway genes are linked to epilepsy, autism, and cognitive dysfunction.
• Research has primarily focused on mTOR's role in excitatory neurons, overlooking potential interneuron involvement.

Purpose of the Study:

• To review clinical evidence and potential mechanisms of interneuron involvement in mTOR-related neurological disorders.
• To explore how mTOR hyperactivation in interneurons contributes to disease pathogenesis using mouse models.

Main Methods:

• Review of clinical data implicating interneurons in mTOR-related disorders.
• Analysis of studies involving selective disruption of mTOR signaling in interneurons and their progenitors in mouse models.

Main Results:

• Dysregulated mTOR signaling in interneurons is a critical factor in neurological dysfunction.
• Studies in mouse models demonstrate that mTOR hyperactivation in interneurons drives disease pathology.

Conclusions:

• Interneuron dysfunction due to mTOR hyperactivation is a significant contributor to epilepsy, autism, and cognitive deficits.
• Cellular mosaicism and dual roles of mTOR signaling present challenges for developing effective treatments.